Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Johnson

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
Science (New York, N.Y.)|January 29, 2021
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systemsShahar Alon, Daniel R Goodwin, Anubhav Sinha, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
The Lancet. Oncology|October 2, 2025
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAF<sup>V600E</sup>-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort studyAlessandro Di Federico, Kaiwen Wang, Monica F Chen, et al.
JCO Precision Oncology|September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk FactorsJoao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
Nature Genetics|March 24, 2020
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinomaDavid J H Shih, Naema Nayyar, Ivanna Bihun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
TTF-1 expression in lung adenocarcinoma: clinicopathologic, genomic, and immunophenotypic correlates and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitorsAlessandro Di Federico, Lingzhi Hong, Arielle Elkrief, et al.
Cancer Discovery|September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsPriscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Nature Medicine|June 27, 2020
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumorsMichal Slyper, Caroline B M Porter, Orr Ashenberg, et al.
Nature Medicine|May 15, 2020
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumorsMichal Slyper, Caroline B M Porter, Orr Ashenberg, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Science (New York, N.Y.)|January 29, 2021
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systemsShahar Alon, Daniel R Goodwin, Anubhav Sinha, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
The Lancet. Oncology|October 2, 2025
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAF<sup>V600E</sup>-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort studyAlessandro Di Federico, Kaiwen Wang, Monica F Chen, et al.
JCO Precision Oncology|September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk FactorsJoao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
Nature Genetics|March 24, 2020
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinomaDavid J H Shih, Naema Nayyar, Ivanna Bihun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
TTF-1 expression in lung adenocarcinoma: clinicopathologic, genomic, and immunophenotypic correlates and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitorsAlessandro Di Federico, Lingzhi Hong, Arielle Elkrief, et al.
Cancer Discovery|September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsPriscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Nature Medicine|June 27, 2020
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumorsMichal Slyper, Caroline B M Porter, Orr Ashenberg, et al.
Nature Medicine|May 15, 2020
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumorsMichal Slyper, Caroline B M Porter, Orr Ashenberg, et al.
Pageof 25